PERSPECTA

News from every angle

Back to headlines

Dyne Therapeutics Shares Decline After $375 Million Public Offering

Shares of Dyne Therapeutics experienced a slide following the pricing of its $375 million public offering.

22 Jul, 12:29 — 22 Jul, 12:29
PostShare

Sources

Showing 1 of 1 sources